title: Ethics of ART interruption after stem-cell transplantation.
authors.affiliation: Johns Hopkins Berman Institute of Bioethics and Department of Medicine, Baltimore, MD, USA; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, VIC, AUS. Electronic address: jsugarman@jhu.edu.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Sugarman
authors.affiliation: The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, VIC, AUS; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
authors.forename: Sharon R
authors.initials: SR
authors.lastname: Lewin
authors.affiliation: Division of Experimental Medicine, University of California San Francisco, San Francisco, CA, USA.
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Henrich
authors.affiliation: The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, VIC, AUS.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Rasmussen
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000188:drug therapy / Q000628:therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D018380:Hematopoietic Stem Cell Transplantation / Q000941:ethics*; D006801:Humans
chemical_list: D019380:Anti-HIV Agents